Press Releases

DUBLIN — January 24, 2019 — Medtronic plc (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire EPIX Therapeutics, Inc. (EPIX), a privately-held medical device company that designs and manufactures a novel, catheter-based, temperature-controlled cardiac ablation…
LEIPZIG and MARLBOROUGH, Mass. (January 22, 2019) — Boston Scientific (NYSE: BSX) today announced diabetic subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of target lesion…
LEIPZIG, Germany and MARLBOROUGH, Mass., Jan. 22, 2019 — Today, Boston Scientific (NYSE: BSX) announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT® System for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target…
GREENVILLE, N.C. — RFPi Inc. has received 510(k) clearance from the U.S. Food and Drug Administration to begin marketing for use by surgeons in open surgery its iCertainty™ blood flow and perfusion imaging medical device. RFPi’s proprietary product shows real-time blood flow and perfusion in…
Researchers at the University of Cincinnati (UC) have received a $3.2 million grant from the National Institute of Neurological Diseases (NINDS) to study the use of neuroimaging to pinpoint the risk factors of stroke recurrence. It is the first-ever R01 grant for the Department of Radiology at…
(Miami – January 2, 2019) – Joseph Lamelas, M.D., an internationally recognized expert cardiac surgeon who helped pioneer minimally invasive approaches to cardiac surgery, has joined the University of Miami Health System as chief of cardiothoracic surgery and professor of surgery within the…
VALHALLA, N.Y., Dec. 17, 2018 — Retia Medical, LLC, a medical device company focused on advancing the quality and clinical use of hemodynamic monitoring, today announced that its Argos Cardiac Output (CO) Monitor has received U.S. Food and Drug Administration 510k clearance and is now available…
RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 13, 2018 — The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people with type 2 diabetes and cardiovascular disease through evaluation of a multidisciplinary approach at cardiology clinics across the U.S. The…
DUBLIN — December 10, 2018 — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America's Most JUST Companies in 2018, according to Forbes magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues…
RALEIGH, N.C., Dec. 7, 2018—Contego Medical announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Vanguard IEP® Peripheral Balloon Angioplasty System with Integrated Embolic Protection. Contego Medical is a medical device company developing and…
REDWOOD CITY, Calif.— HeartFlow, Inc. today announced the start of the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) trial. The first patient was enrolled by Michael C. Turner, M.D., at Imperial Health Cardiovascular Specialists in…
BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter. The BTG Sentry filter is designed to provide protection from Pulmonary…
DUBLIN — December 3, 2018 — Medtronic plc (NYSE:MDT) today announced the first patient treated in the TERMINATE AF trial, a multi-center study evaluating two surgical ablation devices — the Cardioblate(TM) Irrigated RF (IRF) System and the CryoFlex(TM) Surgical Ablation System — for the…
Santa Monica, CA, Nov. 27, 2018 - BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the…
DUBLIN - November 20, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2019, which ended October 26, 2018. The company reported second quarter worldwide revenue of $7.481 billion, an increase of 6.1 percent as reported or 7.5 percent on an…
REDWOOD CITY, CA / November 15, 2018 / Avinger, Inc. (AVGR), a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD), today announced the successful treatment of…
DUBLIN - November 13, 2018 - Medtronic plc (NYSE:MDT) today announced it has received CE Mark approval for the Valiant Navion(TM) thoracic stent graft system for the minimally invasive repair of all lesions of the descending thoracic aorta, including thoracic aortic aneurysms (TAA), blunt…
CHICAGO, Nov. 11, 2018 — Developing novel approaches to understand cardiovascular health and pre-disease is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice chair for Scientific Innovation in the department of Medicine at Brigham and Women's…
DUBLIN — November 8, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin a clinical trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension) who are already prescribed anti-…
DUBLIN and LAS VEGAS — November 6, 2018 — Medtronic plc (NYSE:MDT) data presented today reinforce the durability, safety, and effectiveness of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) in the superficial femoral (SFA) and popliteal…
MARLBOROUGH, Mass. (November 6, 2018) — Boston Scientific (NYSE: BSX) today announced clinical outcomes from the IMPERIAL Long Lesion Sub-study demonstrating that the Eluvia™ Drug-Eluting Vascular Stent System is safe and effective in treating patients with long, complex, calcified lesions…